| Title | Author(s) | Year | View Count |
 | Effects of fish oil on plasma fibrinolysis in patients with mild rheumatoid arthritis | Lau, CS; McLaren, M; Belch, JJF | 1995 | 114 |
| Reduced red blood cell deformability in patients with rheumatoid vasculitis: Improvement after in vitro treatment with dipyridamole | Lau, CS; Saniabadi, AR; Belch, JJF | 1995 | 91 |
| Digital blood flow response to body warming, cooling, and rewarming in patients with Raynaud's phenomenon | Lau, CS; Khan, F; Brown, R; McCallum, P; Belch, JJF | 1995 | 103 |
 | Oral iloprost as a treatment for Raynaud's syndrome: A double blind multicentre placebo controlled study | Belch, JJF; Capell, HA; Cooke, ED; Kirby, JDT; Lau, CS; Madhok, R; Murphy, E; Steinberg, M | 1995 | 249 |
| Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis | Lau, CS; Mclaren, M; Hanslip, J; Kerr, M; Belch, JJF | 1993 | 36 |
| Increased whole blood platelet aggregation in patients with Raynaud's phenomenon with or without systemic sclerosis | Lau, CS; Mclaren, M; Saniabadi, A; Belch, JJF | 1993 | 47 |
| Cicaprost, an orally active prostacyclin analogue: Its effects on platelet aggregation and skin blood flow in normal volunteers | Belch, JJF; Mclaren, M; Lau, CS; Mackay, IR; Bancroft, A; Mcewen, J; Thompson, JM | 1993 | 48 |
| Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon | Lau, CS; Mclaren, M; Mackay, I; Belch, JJF | 1993 | 42 |
| A randomised, double-blind study of Cicaprost, an oral prostacyclin analogue, in the treatment of Raynaud's phenomenon secondary to systemic sclerosis | Lau, CS; Belch, JJF; Madhok, R; Cappell, H; Herrick, A; Jayson, M; Thompson, JM | 1993 | 48 |
| Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis - A double-blind placebo controlled study | Lau, CS; Morley, KD; Belch, JJF | 1993 | 38 |
| Snake oil [4] | Ackman, RG; Belch, JJF; Ross, P; Lau, CS | 1992 | 61 |
| Authors' reply | Belch, JJF; Ross, P; Lau, CS | 1992 | 1,164 |
| White blood cell activation in Raynaud's phenomenon of systemic sclerosis and vibration induced white finger syndrome | Lau, CS; O'dowd, A; Belch, JJF | 1992 | 53 |
| Further evidence of increased polymorphonuclear cell activity in patients with Raynaud's phenomenon | Lau, CS; Bridges, AB; Muir, A; Scott, N; Bancroft, A; Belch, JJF | 1992 | 39 |
| The effects of thromboxane receptor blockade on platelet aggregation and digital skin blood flow in patients with secondary Raynaud's syndrome | Lau, CS; Khan, F; Mclaren, M; Bancroft, A; Walker, M; Belch, JJF | 1991 | 54 |
| The pharmacological effects of cicaprost, an oral prostacyclin analogue, in patients with Raynaud's syndrome secondary to systemic sclerosis - a preliminary study | Lau, CS; Mclaren, M; Saniabadi, A; Scott, N; Belch, JJF | 1991 | 60 |
| Raynaud's phenomenon a vasospastic disorder | Lau, CS; Belch, JJF | 1991 | 30 |
| Increased activity of oxygen free radicals during reperfusion in patients with peripheral arterial disease undergoing percutaneous peripheral artery balloon angioplasty | Lau, CS; Scott, N; Shaw, JW; Belch, JJF | 1991 | 57 |
| Iloprost and risk of thromboembolism [2] | Belch, JJF; Lau, CS; Saniabadi, A; Mclaren, M; Forbes, CD; Kovacs, IB | 1991 | 36 |
| Factor VIII Von Willebrand factor antigen levels correlaie with symptom severity in patients with Raynaud's phenomenon | Lau, CS; Mclaren, M; Belch, JJF | 1991 | 48 |
|
